KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Aurinia Pharmaceuticals (AUPH) Return on Sales (2018 - 2025)

Historic Return on Sales for Aurinia Pharmaceuticals (AUPH) over the last 10 years, with Q3 2025 value amounting to 0.43%.

  • Aurinia Pharmaceuticals' Return on Sales rose 2200.0% to 0.43% in Q3 2025 from the same period last year, while for Sep 2025 it was 0.29%, marking a year-over-year increase of 4000.0%. This contributed to the annual value of 0.02% for FY2024, which is 4700.0% up from last year.
  • According to the latest figures from Q3 2025, Aurinia Pharmaceuticals' Return on Sales is 0.43%, which was up 2200.0% from 0.31% recorded in Q2 2025.
  • Aurinia Pharmaceuticals' 5-year Return on Sales high stood at 0.43% for Q3 2025, and its period low was 55.12% during Q1 2021.
  • Over the past 5 years, Aurinia Pharmaceuticals' median Return on Sales value was 0.28% (recorded in 2023), while the average stood at 3.78%.
  • In the last 5 years, Aurinia Pharmaceuticals' Return on Sales surged by 14493300bps in 2021 and then tumbled by -900bps in 2023.
  • Quarter analysis of 5 years shows Aurinia Pharmaceuticals' Return on Sales stood at 1.42% in 2021, then skyrocketed by 36bps to 0.92% in 2022, then surged by 35bps to 0.6% in 2023, then soared by 104bps to 0.02% in 2024, then soared by 1645bps to 0.43% in 2025.
  • Its Return on Sales stands at 0.43% for Q3 2025, versus 0.31% for Q2 2025 and 0.37% for Q1 2025.